Trial Profile
Oral Vinorelbine And Cisplatin With Concomitant Radiotherapy Followed By Either Consolidation Therapy With Oral Vinorelbine And Cisplatin Plus Best Supportive Care Or Best Supportive Care Alone In Stage III Non Small Cell Lung Cancer (NSCLC), A Randomized Phase III Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Nov 2021
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Cisplatin
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms GILT
- Sponsors Pierre Fabre
- 01 Oct 2021 Results retrospectively analysing pre-therapeutic FFPE tumour tissue from patients enrolled in the GILT trial and assessing prognostic role of PD-L1 and TiLs in locally advanced NSCLC, published in the Lung Cancer
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 08 Oct 2010 Preliminary results have been presented at the 35th Congress of the European Society for Medical Oncology (ESMO).